Thalassemia

Landscape Report →
45 active trials
9 Phase 3
20 recruiting
29 sponsors
Updated daily from ClinicalTrials.gov
Top sponsors National Heart, Lung, and Blood Institute (NHLBI) (5) Agios Pharmaceuticals, Inc. (5) CorrectSequence Therapeutics Co., Ltd (4) Vertex Pharmaceuticals Incorporated (3) National Institute of Allergy and Infectious Diseases (NIAID) (2)